C. Marchand

723 total citations
27 papers, 440 citations indexed

About

C. Marchand is a scholar working on Surgery, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, C. Marchand has authored 27 papers receiving a total of 440 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Surgery, 5 papers in Molecular Biology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in C. Marchand's work include Health, Medicine and Society (3 papers), Bacillus and Francisella bacterial research (3 papers) and Prostate Cancer Treatment and Research (3 papers). C. Marchand is often cited by papers focused on Health, Medicine and Society (3 papers), Bacillus and Francisella bacterial research (3 papers) and Prostate Cancer Treatment and Research (3 papers). C. Marchand collaborates with scholars based in France, United States and Pakistan. C. Marchand's co-authors include Alexandre de la Taille, Francis Vacherot, Stéphane Terry, Yves Allory, Laurent Salomon, Nathalie Nicolaı̈ew, J Thivolet, Guillaume Ploussard, Jean Kanitakis and A Calame and has published in prestigious journals such as Journal of Medicinal Chemistry, Antimicrobial Agents and Chemotherapy and European Urology.

In The Last Decade

C. Marchand

26 papers receiving 426 citations

Peers

Countries citing papers authored by C. Marchand

Since Specialization

Citations

This map shows the geographic impact of C. Marchand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Marchand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Marchand more than expected).

Fields of papers citing papers by C. Marchand

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Marchand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Marchand. The network helps show where C. Marchand may publish in the future.

Co-authorship network of co-authors of C. Marchand

This figure shows the co-authorship network connecting the top 25 collaborators of C. Marchand. A scholar is included among the top collaborators of C. Marchand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Marchand. C. Marchand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Shiga-Toxin-Producing Strains of Escherichia coli O104:H4 and a Strain of O157:H7, Which Can Cause Human Hemolytic Uremic Syndrome, Differ in Biofilm Formation in the Presence of CO2 and in Their Ability to Grow in a Novel Cell Culture Medium 2023 ·Microorganisms ·Kei Amemiya, David A. Rozak, (unknown), (unknown), C. Marchand, David P. Fetterer, Patricia L. Worsham, B K Purcell	5
2	Open retromuscular large mesh reconstruction of lumbar incisional hernias including the atrophic muscular area 2017 ·Hernia ·Yohann Renard, Louis de Mestier, (unknown), (unknown), C. Marchand, (unknown), Réza Kianmanesh, J. P. Palot	18
3	Éventrations lombaires symptomatiques après néphrectomies par lombotomie : quels sont les facteurs de risque ? 2016 ·Progrès en Urologie ·C. Marchand, Yohann Renard, C. Avisse, J. P. Palot, S. Larré	6
4	Implication of NPM1 phosphorylation and preclinical evaluation of the nucleoprotein antagonist N6L in prostate cancer 2016 ·Oncotarget ·Damien Destouches, (unknown), Stéphane Terry, C. Marchand, Pascale Maillé, Pascale Soyeux, Gilles Carpentier, (unknown), Jocelyn Céraline, Yves Allory, José Courty, Alexandre de la Taille, Francis Vacherot	17
5	In Vitro Antibiotic Susceptibilities of Yersinia pestis Determined by Broth Microdilution following CLSI Methods 2015 ·Antimicrobial Agents and Chemotherapy ·Henry S. Heine, Jeremy R. Hershfield, C. Marchand, (unknown), (unknown), Bret K. Purcell, Patricia L. Worsham	24
6	L’obésité est-elle un frein à la transplantation rénale ? 2014 ·Progrès en Urologie ·(unknown), (unknown), C. Marchand, (unknown), (unknown), (unknown), (unknown), S. Larré	3
7	Impact de l’obésité sur la fonction rénale à 1 an chez les transplantés rénaux : expérience mono centrique 2014 ·Progrès en Urologie ·(unknown), (unknown), C. Marchand, (unknown), (unknown), (unknown), (unknown), (unknown), S. Larré	1
8	D-cycloserine or similar physiochemical compounds may be uniquely suited for use inBacillus anthracisspore decontamination strategies 2013 ·Journal of Applied Microbiology ·(unknown), (unknown), Christopher P. Klimko, C. Marchand, (unknown), (unknown), Joel A. Bozue, Susan L. Welkos, Christopher K. Cote	14
9	3-Substituted Indole Inhibitors Against Francisella tularensis FabI Identified by Structure-Based Virtual Screening 2013 ·Journal of Medicinal Chemistry ·Xin Hu, Jaimee R. Compton, Mohamed Diwan M. AbdulHameed, C. Marchand, Kelly L. Robertson, Dagmar H. Leary, Ajit Jadhav, Jeremy R. Hershfield, Anders Wallqvist, Arthur M. Friedlander, Patricia M. Legler	16
10	The role of American Society of Anesthesiologists scores in predicting urothelial carcinoma of the upper urinary tract outcome after radical nephroureterectomy: results from a national multi‐institutional collaborative study 2012 ·British Journal of Urology ·(unknown), Pierre Colin, David Yates, A. Ouzzane, Marie Audouin, (unknown), (unknown), C. Marchand, Pierre Bigot, M. Soulié, M. Roumiguié, T. Polguer, (unknown), (unknown), E. Ravier, Y. Neuzillet, (unknown), Thomas Bodin, G. Pignot, Morgan Rouprêt, (unknown)	22
11	Prospective Evaluation of an Extended 21-Core Biopsy Scheme as Initial Prostate Cancer Diagnostic Strategy 2012 ·European Urology ·Guillaume Ploussard, Nathalie Nicolaı̈ew, C. Marchand, Stéphane Terry, Francis Vacherot, Dimitri Vordos, Yves Allory, Claude-Clément Abbou, Laurent Salomon, Alexandre de la Taille	44
12	Comparison of oncological outcomes after segmental ureterectomy or radical nephroureterectomy in urothelial carcinomas of the upper urinary tract: results from a large French multicentre study 2012 ·British Journal of Urology ·Pierre Colin, A. Ouzzane, G. Pignot, E. Ravier, Sébastien Crouzet, (unknown), Marie Audouin, Y. Neuzillet, Baptiste Albouy, S. Hurel, Fabien Saint, J. Guillotreau, Laurent Guy, Pierre Bigot, Alexandre de la Taille, (unknown), C. Marchand, (unknown), (unknown), Morgan Rouprêt, (unknown)	91
13	Demander leur avis aux patients, qu'est-ce que cela change?! 2001 ·Soins Psychiatrie ·(unknown), (unknown), (unknown), Juliette Bloch, (unknown), C. Marchand	1
14	[Oral hairy leukoplakia in AIDS. Histologic and ultrastructural study of 8 cases]. 1990 ·PubMed ·Jean Kanitakis, Giovanna Zambruno, C. Marchand, (unknown), C Hermier, J Thivolet	2
15	Immunohistochemical Study of Normal Skin of HIV-1—Infected Patients Shows No Evidence of Infection of Epidermal Langerhans Cells by HIV 1989 ·AIDS Research and Human Retroviruses ·Jean Kanitakis, C. Marchand, Hong Su, J Thivolet, (unknown), Daniel Schmitt, (unknown)	46
16	Urticaire systémique associée à une thyroïdite auto-immune 1987 ·La Revue de Médecine Interne ·(unknown), C. Marchand, (unknown), C Hermier, H Perrot	6
17	[Donovanosis. Apropos of a new case of granuloma inguinale in France]. 1986 ·PubMed ·C. Marchand, (unknown), (unknown), J Thivolet	1
18	[Trichorhinophalangeal syndrome. Apropos of a case]. 1985 ·PubMed ·C. Marchand, (unknown), H Plauchu, (unknown), B Chouvet	1
19	Cerebral distress in full-term newborns and its prognostic value. A follow-up study of 90 infants. 1976 ·PubMed ·(unknown), A Calame, C. Marchand, Mirko Passera, (unknown), (unknown)	18
20	[Treatment of Trichomonas vaginitis by oral & local route with 2-acetylamino-5-nitrothiazole]. 1957 ·PubMed ·(unknown), (unknown), C. Marchand	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact